ConductScience.org, home

Paper24216

Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency.

Schrader WP and 2 others. Proc Natl Acad Sci U S A, 1978. Cited by 73 papers, by iCite.

Cite this record

ConductScience Library. Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency. Papers, record 24216. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24216

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
73
iCite
Relative citation ratio, by iCite
1.76
iCite
Revised in PubMed
2019-05-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schrader WPW P
2Pollara BB
3Meuwissen HJH J

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adenosine DeaminaseMajor topic
Immunologic Deficiency SyndromesMajor topic
Nucleoside DeaminasesMajor topic
SpleenMajor topic
Adenine
Adenosine
Cross Reactions
Hydrogen-Ion Concentration
Kinetics

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11061119Characterization of residual enzyme activity in fibroblasts from patients with adenosine deaminase deficiency and combined immunodeficiency: evidence for a mutant enzyme.Proc Natl Acad Sci U S A1976https://conductscience.org/library/papers/1061119PubMed
21089440Combined immunodeficiency disease associated with adenosine deaminase deficiency. Report on a workshop held in Albany, New York, October 1, 1973.J Pediatr1975https://conductscience.org/library/papers/1089440PubMed
31089883Severe combined immunodeficiency and adenosine deaminase deficiency.N Engl J Med1975https://conductscience.org/library/papers/1089883PubMed
41117071Conversion of human erythrocyte-adenosine deaminase activity to different tissue-specific isozymes. Evidence for a common catalytic unit.J Clin Invest1975https://conductscience.org/library/papers/1117071PubMed
51155449Heterogeneity for adenosine deaminase deficiency: Expression of the enzyme in cultured skin fibroblasts and amniotic fluid cells.Am J Hum Genet1975https://conductscience.org/library/papers/1155449PubMed
613062Human adenosine deaminase. Purification and subunit structure.J Biol Chem1977https://conductscience.org/library/papers/13062PubMed
84117384Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.Lancet1972https://conductscience.org/library/papers/4117384PubMed
94158310Estimation of the molecular weights of proteins by Sephadex gel-filtration.Biochem J1964https://conductscience.org/library/papers/4158310PubMed
104521417Purification and properties of cytidine deaminase from normal and leukemic granulocytes.J Clin Invest1974https://conductscience.org/library/papers/4521417PubMed
114625871Multiple forms of human adenosine deaminase. I. Purification and characterization of two molecular species.Biochim Biophys Acta1972https://conductscience.org/library/papers/4625871PubMed
124721618Partial purification and properties of the common inherited forms of adenosine deaminase from human erythrocytes.Biochem J1973https://conductscience.org/library/papers/4721618PubMed
134808472Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines.J Med Chem1974https://conductscience.org/library/papers/4808472PubMed
144827825Molecular form of adenosine deaminase in severe combined immunodeficiency.Biochem Biophys Res Commun1974https://conductscience.org/library/papers/4827825PubMed
155096426Inhibition of the indophenol reaction in the spectrophotometric determination of ammonia.Clin Chim Acta1971https://conductscience.org/library/papers/5096426PubMed
165159535Adenosine deaminase isozymes in human tissues.Ann Hum Genet1971https://conductscience.org/library/papers/5159535PubMed
175806584The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.J Biol Chem1969https://conductscience.org/library/papers/5806584PubMed
185822324Further data on the adenosine deaminase (ADA) polymprphism and a report of a new phenotype.Ann Hum Genet1969https://conductscience.org/library/papers/5822324PubMed
19893413Purification and subunit structure of adenosine deaminase from human kidney.J Biol Chem1977https://conductscience.org/library/papers/893413PubMed
20932020Purification of human erythrocyte adenosine deaminase by affinity column chromatography.J Biol Chem1976https://conductscience.org/library/papers/932020PubMed
219388Human adenosine deaminase. Distribution and properties.J Biol Chem1976https://conductscience.org/library/papers/9388PubMed

Download CSV of references

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.

PMIDTitleJournalYearIn PapersSource
42312136ADA2 genotype and enzyme activity may predict vasculitic or hematologic DADA2 phenotype.J Hum Immun2026https://conductscience.org/library/papers/42312136PubMed
41484495A Review of Adenosine Deaminase 2 (ADA2) as a Biomarker of Monocyte/Macrophage Activation.Curr Allergy Asthma Rep2026https://conductscience.org/library/papers/41484495PubMed
41359379The lysosomal catabolism of nucleic acids-critical regulators of the innate immune system.Nucleic Acids Res2025https://conductscience.org/library/papers/41359379PubMed
40505866Structural basis for the substrate specificity of Helix pomatia AMP deaminase and a chimeric ADGF adenosine deaminase.J Biol Chem2025https://conductscience.org/library/papers/40505866PubMed
39956283Getting to know adenosine deaminase 2 deficiency inside and out.J Allergy Clin Immunol2025https://conductscience.org/library/papers/39956283PubMed
38970744Human ADA2 Deficiency: Ten Years Later.Curr Allergy Asthma Rep2024https://conductscience.org/library/papers/38970744PubMed
38777862ADA2 regulates inflammation and hematopoietic stem cell emergence via the A2bR pathway in zebrafish.Commun Biol2024https://conductscience.org/library/papers/38777862PubMed
36407219A Rare Genetic Mutation Leading to a Deficiency of Adenosine Deaminase 2 Enzyme in a Long-Standing Case of Cutaneous Polyarteritis Nodosa: A Case Report.Cureus2022https://conductscience.org/library/papers/36407219PubMed
35663977Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis.Front Immunol2022https://conductscience.org/library/papers/35663977PubMed
35178658Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2).Semin Immunopathol2022https://conductscience.org/library/papers/35178658PubMed
34881804Adenosine deaminase, not immune to a mechanistic rethink in central nervous system disorders?Histol Histopathol2022https://conductscience.org/library/papers/34881804PubMed
34122398Plasma Adenosine Deaminase (ADA)-1 and -2 Demonstrate Robust Ontogeny Across the First Four Months of Human Life.Front Immunol2021https://conductscience.org/library/papers/34122398PubMed
34054547Metabolic Aspects of Adenosine Functions in the Brain.Front Pharmacol2021https://conductscience.org/library/papers/34054547PubMed
34004258Comprehensive analysis of ADA2 genetic variants and estimation of carrier frequency driven by a function-based approach.J Allergy Clin Immunol2022https://conductscience.org/library/papers/34004258PubMed
32650798Adenosine deaminase 2 activity negatively correlates with age during childhood.Pediatr Rheumatol Online J2020https://conductscience.org/library/papers/32650798PubMed
31707357Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.Ann Rheum Dis2020https://conductscience.org/library/papers/31707357PubMed
31541281The same mutation in a family with adenosine deaminase 2 deficiency.Rheumatol Int2021https://conductscience.org/library/papers/31541281PubMed
30406060Vasculopathy, Immunodeficiency, and Bone Marrow Failure: The Intriguing Syndrome Caused by Deficiency of Adenosine Deaminase 2.Front Pediatr2018https://conductscience.org/library/papers/30406060PubMed
29951947Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.J Clin Immunol2018https://conductscience.org/library/papers/29951947PubMed
29769837The Role of Extracellular Adenosine Generation in the Development of Autoimmune Diseases.Mediators Inflamm2018https://conductscience.org/library/papers/29769837PubMed

See all 32 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ADA100PubTator's text mininghttps://conductscience.org/library/genes/100

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24216

GET https://conductscience.org/api/papers/v1/24216/cited_by?page=2